Administration of Warm Blood Cardioplegia With or Without Roller Pump

NACompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Coronary Disease
Interventions
OTHER

No pump

In the no pump group blood cardioplegia was delivered using the arterial line pressure, created by the arterial centrifugal pump of the cardiopulmonary bypass system. Blood cardioplegia flow depended on the difference between arterial line pressure and aortic root pressure.

OTHER

Pump

In the pump group blood cardioplegia was delivered using a roller pump. The blood cardioplegia flow was given at 200 mL/min.

OTHER

Blood sample collection: after induction of anaesthesia (T0)

The following biomarkers were analysed: TnT-hs, H-FABP, NT-pro-BNP and CRP.

OTHER

Blood sample collection: after arrival at the ICU (T1)

The following biomarkers were analysed: TnT-hs, H-FABP, NT-pro-BNP and CRP.

OTHER

Blood sample collection: 4 hours in ICU (T2)

The following biomarkers were analysed: TnT-hs, H-FABP, NT-pro-BNP and CRP.

OTHER

Blood sample collection: the first postoperative day (T3)

The following biomarkers were analysed: TnT-hs, H-FABP, NT-pro-BNP and CRP.

Trial Locations (1)

3435 CM

St. Antonius Hospital, Nieuwegein

All Listed Sponsors
lead

St. Antonius Hospital

OTHER

NCT02248415 - Administration of Warm Blood Cardioplegia With or Without Roller Pump | Biotech Hunter | Biotech Hunter